RSS

Editor's Desk

With worldwide orphan drug sales predicted to grow at a significant rate and each drug fetching a hefty price tag, I look at this market and its drivers in a bit more detail… more

Opinion

As the race to dominate the artificial intelligence (AI) space steps up a gear, I take a look at how AI finds use in pharma and how different regions plan to invest in this exciting area. more

Opinion

Despite the ongoing trend in digital tech across the board, pharma is still lagging behind in unlocking the potential of these useful tools… more

Opinion

With recent plans announced by the UK’s prime minister to remain part of the EMA, which would be favourable for many in the pharma industry, I will look at these developments as well as how they will impact industry and the reactions from leaders more

Opinion

As we embark on a difficult flu season, I look at why infection rates vary so much year on year and the potential universal vaccine one company is progressing through the clinical development stages. more

Opinion

Oral solid dosage forms are still the preferred method of delivery for the pharma industry but what challenges are encountered and how does the industry solve these potential problems? more

Opinion

If you are considering a quick winter getaway or some last minute sunshine over the festive period, make sure you check your meds or you may get more than you bargain for… more

Opinion

As we fast approach CPhI Worldwide’s return to Frankfurt, we take a look at what makes the city such a great place for pharma. more

Opinion

Apps are ever more popular and becoming part of daily routine and lifestyle in this digital age, but how are pharma companies measuring up in this space? more

Opinion

R&D efficiency has been in decline for many years, but now with bodies, like the FDA, aiming to accelerate approval times and a critical need for new therapies to combat antibiotic resistant strains of bacteria will we see the tide turn? more

Opinion

Drug delivery is evolving to enhance medicine efficacy and patient compliance in our increasingly digital world. more

Opinion

After recent events, it seems that more than ever protective measures are made to ensure pharma is a safe space for companies and patients. more

Opinion

As the industry realigns itself to some major changes, EPM magazine also has a shake up. more

Opinion

AMR is back in the news (is it ever out?) and with good reason. The World Health Organisation has published a list of drug-resistant bacteria thought to pose the biggest threat to human health. more

News